Breast medical oncologist Jessica Treviño Jones, MD, returns to her San Antonio roots with a mission: to empower her community through cancer education and prevention. From humble beginnings to a leading role in cancer care, her journey inspires hope and change.

Researchers from the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, will present results of multiple lines of study Dec. 7-10 during the 2021 San Antonio Breast Cancer Symposium.

Mays Cancer Center at UT Health San Antonio, in partnership with the American Association for Cancer Research (AACR), is hosting the 46th annual San Antonio Breast Cancer Symposium (SABCS) at the Henry B. Gonzalez Convention Center on Dec. 5-9. This scientific and education symposium, initiated and owned by Mays Cancer Center, is the world’s largest […]

The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was the lead site for a study evaluating Phase I and Phase III clinical trials for elacestrant, a treatment for postmenopausal women and adult men with ER+/HER2- advanced or metastatic breast cancer. The U.S. Food and Drug Administration on Jan. 27 announced it approved the […]

In general, the earlier the cancer is diagnosed the more effective the treatments are at preventing recurrence of breast cancer.

Amidst the rise of COVID-19 and losing her job, the unthinkable happened: Yvonne Martinez was diagnosed with aggressive triple-negative breast cancer.

Marcela Mazo Canola, MD, helps us understand breast cancer signs, symptoms and risks.

Researchers from the Mays Cancer Center at UT Health San Antonio presented results of multiple lines of study during the San Antonio Breast Cancer Symposium, operated in conjunction with the American Association of Cancer Research.

UT Health San Antonio’s Mays Cancer Center is hosting a Grand Rounds Oct. 15 — Global Lobular Breast Cancer Awareness Day — to spotlight new approaches to diagnosis and treatment of invasive lobular carcinoma, a common but often overlooked form of breast cancer.

BRCA1 and BRCA2 are genes that help protect the body by fixing damaged DNA and keeping cells healthy. When these genes have changes, or mutations, they don’t work the way they should. This can raise the risk of certain cancers, like breast, ovarian, prostate and pancreatic cancer. These inherited mutations affect about 1 in every 200 to 300 people — over a million in the U.S. alone.